跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rapirus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rapirus
Approved
STANDARD
Rapirus
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
42e3268bba03c4d6
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
42e3268bba03c4d6
Drug Approval Philippines Name
Rapirus
Product Name
Rapirus
Registration Number
DRP-14750
Brand Name
Rapirus
Generic Name
Ferrous Sulfate + Folic Acid
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg (equivalent to 90 mg elemental Iron)/ 250 mcg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Trader
St. Raphael Archangel Pharmaceutical Product Distribution
Issuance Date
28 December 2023
Expiry Date
28 December 2028
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
42e3268bba03c4d6
Type
Standard
Back to Philippines FDA Approvals